GEA Pharma Systems was formed early in the year 2000 after GEA Group
acquired the pharmaceutical division of GEI International. The newly acquired
brands Buck® - containment interfaces solutions and Buck Systems™ -
contained materials handling, Collette™ - continuous granulation & single
pot technology, Courtoy™ - tablet compression, were combined into GEA
Pharma Systems along with the existing GEA brands, Aeromatic-Fielder ™ and
NICA™- granulation, drying, pelletizing and coating.
With this combination, GEA Pharma Systems became the leading international
supplier of advanced processing technologies for the manufacturing of oral and
parenteral dosage forms for the pharmaceutical industry.
In November 2005 followed the acquisition of the lyophilization business of
Steris Gmbh by GEA Group and the renaming of the company into GEA Lyophil
it joined the other pharma brands in GEA Pharma Systems. GEA Lyophil
supplies specialist freeze drying technology for the pharmaceutical and
biotechnology markets.
GEA Pharma Systems’ activities include partnering with customers to develop
new products and enhance clinical effectiveness; the supply of R&D-scale
and stand-alone production equipment; and the installation of complete
integrated production lines.
Innovation - Tomorrow’s technology today
For GEA Pharma Systems, innovation is the key to our success and to
continued prosperity for our customers. In fact it’s more than that. We know
that by continually stretching the boundaries of what is possible in
pharmaceutical processing we have the ability to support our Customers in
enhancing the opportunities available to millions of people all over the world.
This is what drives our business.
Our innovation takes many forms and affects all parts of the process. We
innovate to increase production and reduce costs, to improve containment and
safeguard the workforce, to achieve better clinical effectiveness and to
enhance quality control. At GEA Pharma Systems the innovation never stops – it’
s just part of what we do.
For example we have pioneered Pharma spray drying to provide unprecedented
control of particle form and release profile for drug development, meeting the
most demanding clinical needs. FlexStream™ (patent pending): our new fluid
bed coating system offers multiple processing from a single bowl providing both
flexibility and cost benefits. MODUL™ and PERFORMA™ tablet presses combine unrivalled
containment with fast product change-over and high productivity. The Buck® MC Valve makes the contained handling
of active pharmaceutical ingredients much easier and less expensive than has
been possible in the past. Consigma™: a unique continuous granulation, drying
and tableting process that drastically reduces time to market of new medicines
and enables the move to a 6-Sigma process; and PharmaConnect™ which enables diverse GEA development
equipment to be docked into a single ‘plug and play’ module with full cGMP
compliance.
Innovation - not just for its own sake but for improved products,
greater safety and enhanced productivity to deliver a better future.
Under the following links you can discover a more indepth corporate
history of the individual brands that make up GEA Pharma
Systems: